Organogenesis Holdings, Inc. (ORGO)
1.67
+0.04
(+2.45%)
USD |
NASDAQ |
Sep 02, 16:00
1.67
0.00 (0.00%)
After-Hours: 16:54
Organogenesis Holdings Cash from Investing (Quarterly) : -1.10M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.10M |
| March 31, 2026 | -3.146M |
| December 31, 2025 | -4.652M |
| September 30, 2025 | -2.235M |
| June 30, 2025 | -3.638M |
| March 31, 2025 | -3.626M |
| December 31, 2024 | -3.361M |
| September 30, 2024 | -2.569M |
| June 30, 2024 | -1.88M |
| March 31, 2024 | -2.222M |
| December 31, 2023 | -3.324M |
| September 30, 2023 | -5.979M |
| June 30, 2023 | -7.499M |
| March 31, 2023 | -7.562M |
| December 31, 2022 | -10.66M |
| September 30, 2022 | -10.40M |
| June 30, 2022 | -6.168M |
| March 31, 2022 | -6.672M |
| December 31, 2021 | -5.227M |
| September 30, 2021 | -16.70M |
| Date | Value |
|---|---|
| June 30, 2021 | -4.512M |
| March 31, 2021 | -4.778M |
| December 31, 2020 | -5.418M |
| September 30, 2020 | -11.96M |
| June 30, 2020 | -1.875M |
| March 31, 2020 | -4.243M |
| December 31, 2019 | -3.458M |
| September 30, 2019 | -1.275M |
| June 30, 2019 | -1.184M |
| March 31, 2019 | -0.317M |
| December 31, 2018 | -1.856M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| cbdMD, Inc. | -0.0181M |
| Guardian Pharmacy Services, Inc. | -3.732M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Agenus, Inc. | 0.267M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -31.65M |
| Cash from Financing (Quarterly) | -12.50M |
| Free Cash Flow | 20.84M |
| Free Cash Flow Per Share (Quarterly) | -0.2545 |
| Free Cash Flow to Equity (Quarterly) | -28.84M |
| Free Cash Flow to Firm (Quarterly) | -32.75M |
| Free Cash Flow Yield | 9.61% |